Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
2.990
-0.210 (-6.56%)
At close: Sep 17, 2025, 4:00 PM EDT
3.040
+0.050 (1.67%)
After-hours: Sep 17, 2025, 7:56 PM EDT
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $679.87 million as of September 17, 2025. Its market cap has increased by 249.08% in one year.
Market Cap
679.87M
Enterprise Value
669.78M
1-Year Change
249.08%
Ranking
Category
Stock Price
$2.99
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $679.87M, a decrease of -31.69%. That is a compound annual growth rate of -5.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 727.62M | 254.96% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | 701.04M | -26.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.15B |
| Johnson & Johnson | 429.89B |
| AbbVie | 388.40B |
| UnitedHealth Group | 307.93B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 232.77B |